Menu Search
Equities

XWELL Inc

V9G0:BER

XWELL Inc

Actions
  • Price (EUR)1.69
  • Today's Change0.08 / 4.97%
  • Shares traded175.00
  • 1 Year change-61.24%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024 08:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

XWELL, Inc. is a global health and wellness holding company. The Company operates through four segments: XpresTest, XpresSpa, Treat, and Naples Wax Center. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the centers for disease control and prevention (CDC’s) bio-surveillance program. XpresTest’s HyperPointe business provides a range of service and support options for its customers, including technical support services and advanced services. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. Treat segment is a wellness brand that provides access to wellness services for travelers at on-site centers. Naples Wax Center segment operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.

  • Revenue in USD (TTM)30.11m
  • Net income in USD-27.74m
  • Incorporated2006
  • Employees266.00
  • Location
    XWELL Inc254 WEST 31ST STREET, 11TH FLOORNEW YORK 10001United StatesUSA
  • Phone+1 (212) 750-9595
  • Fax+1 (302) 636-5454
  • Websitehttps://www.xwell.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		XWEL:NAQ since
announced		Transaction
value
Naples Wax Center IncDeal completed12 Sep 202312 Sep 2023Deal completed-44.58%1.50m
Data delayed at least 15 minutes, as of May 15 2024 20:58 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.